[ad_1]
Dublin's Celibacy Children's Hospital Crumlin has an overview of how the patient had told her incorrectly that she had no cancerous gene.
Since then, the patient has been diagnosed with ovarian cancer and is very sick.
The problem is related to the Department of Clinical Genetics of the Hospital.
"RTÉ News" has learned that the staff member is on vacation arising from the events.
Our Lady's Children's Hospital announced that we could not discuss individual patient cases.
Details of the case have been reported in the Irish edition of The Sunday Times.
It is understood that blood tests for what is called Crumlin are called "BRACA 1" gene testing in the UK Hospital in September 2009.
The UK hospital announced a positive gene test and said Crumlin, but it was not passed on to the patient.
A positive result means that the patient has a much higher risk of developing breast or ovarian cancer than a person who does not have a BRACA gene mutation.
It is expected that the hospital report will check that Crumlin has not been correctly informed by the woman.
RTÉ News understands that patients have been diagnosed with cancer and treated this year.
After the questions, the Crumlin Hospital told RTÉ News that it has committed itself to a culture that promotes open and positive approach to incident management.
It announced that the hospital was following the HSE incident management system for reporting incidents.
The hospital stated that in July 2018, Crumlin provided additional funds to support the Department of Clinical Genetics in order to improve the services.
Crumlin said an outsourced multi-professional team led by an experienced healthcare manager working in the UK helped the California Department of Genetics provide improved services to patients and clinical users.
[ad_2]
Source link
